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Objectives: The mode of delivery in diabetic patients is
debatable. This study was designed to assess the pattern
of delivery of macrosomic babies with a high prevalence
of diabetes mellitus in Bahrain.
Methods: This retrospective analysis was conducted on
mothers who delivered babies weighing 4.0 Kgs from
2001 to 2011 at Bahrain Defence Force Hospital. Data
regarding patients’ age, weight, mode of delivery, dia-
betic status, gestational age and parity were recorded.
The main outcome was the effect of diabetes mellitus
on the decision to allow vaginal delivery for macro-
cosmic babies. Other outcomes were failed trial of la-
bour, parity, maternal age and foetal weight on the trial
of labour and neonatal morbidity associated with
vaginal births.
Results: The incidence of macrosomic babies was 2.2%
of total births. Pre-existing diabetes mellitus was 3.9% of
the study cohort. The rate of elective Caesarean section
increased from 12.5% in non-diabetic mothers to 50% in
patients with pre-existing diabetes. In cases of allowing a
trial of labour, approximately 70% of patients with pre-
existing diabetes had successful vaginal delivery. Patients
with a previous delivery were less likely to undergo
emergency procedures, but had the same probability for
elective Caesarean compared with primigravida. Patient’s
age and foetal weight had no influence on successful trial
of vaginal birth.
Conclusions: There was a trend to offer more elective
Caesarean sections in patients with macrosomic babies in
the presence of pre-existing diabetes. The majority ofy. This is an open access article under the CC BY-NC-ND license
.1016/j.jtumed.2016.07.008
B.S. Al Omran et al.56patients who were offered a trial of labour achieved
vaginal delivery with minimal morbidity.
Keywords: Caesarean section; Diabetes; Foetal macrosomia;
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 2016 The Authors.
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NC-ND license (http://creativecommons.org/licenses/by-nc-
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Macrosomia is defined by the American College of Ob-
stetricians and Gynecologists (ACOG) as a birth-weight over
4000 g with no correlation to gestational age.1 Macrosomia
affects approximately 3e15% of all pregnancies. The
diagnosis can only be confirmed retrospectively after
delivery of the neonate.2 Genetic, ethnic and racial factors
are associated with foetal macrosomia.3 Pre-gestational
diabetes results in foetal macrosomia in 40% of
pregnancies.3
Furthermore, when patients have gestational diabetes, the
risk of having macrosomic babies increases to 50%.4 A KSA
study was conducted from 2004 to 2006 and confirmed the
prevalence of macrosomic babies to be 5.6% using the
same birth weight definition.4 Another recent large birth
cohort Kuwaiti study reported macrosomia in 6.1% of the
cohort, and 23.0% of babies were large for their
gestational age.5
Macrosomia can cause numerous perinatal and maternal
complications.6 Large babies can be traumatized during
vaginal birth, especially those with shoulder presentation.
Even with an uncomplicated delivery, macrosomic babies,
especially those born to diabetic mothers, have an
increased incidence of admission to intensive care infant
units to regulate their blood sugar levels and electrolytes.
Macrosomia can also lead to maternal complications, such
as prolonged labour, Caesarean delivery (CSD), labour
assisted with oxytocin, postpartum haemorrhage, infection,
serious perineal tears of the 3rd and 4th degree,
thromboembolic events (DVT) and anaesthetic accidents.7
To prevent any chance of birth trauma to mother and
baby, some authors suggested induction of labour before 40
gestational weeks, others recommend routine Caesarean
section (CS) for the delivery of foetuses >4500 g.8 Al-
Haddabi’s group reported that among 7367 deliveries in a
three-year study conducted in the Department of Obstetrics
and Gynecology, Sultan Qaboos University Hospital, Sul-
tanate of Oman, the CS rates were increased in the macro-
somic group compared with the general group (25.8% vs.
13.1%).9 Ultrasound techniques are not very reliable in
detecting and diagnosing macrosomia.10
Unfortunately, there are still no clear guidelines govern-
ing the management of macrosomia in diabetic patients, and
this issue should be given serious consideration due to its
consequence.
The present retrospective analysis aims to assess the mode
of delivery in patients with large babies associated withdifferent types of diabetes. The analysis also assessed other
factors that might influence the clinical decision and final
outcome.
Materials and Methods
Data were collected retrospectively at the BDFMH. Pa-
tients who gave birth to babies weighing 4.0 Kgs were
included. Patients’ birth records and birth registry were
reviewed between 2001 and 2011. The mode of delivery was
recorded in the form of vaginal, emergency lower segment
Caesarean section (LSCS) and elective LSCS. Cases were
divided into three groups: non-diabetic, gestational diabetes
and pre-existing diabetes. All pregnant women included in
the study were screened with the 50-g glucose tolerance test at
approximately 20 weeks of gestation. Patients who screened
positive were subject to a full glucose tolerance test. Patients
with one abnormal reading were considered to be glucose
intolerant. Patients with two abnormal readings were
confirmed to have gestational diabetics. In our analysis, BDF
Hospital patients with glucose intolerance were included in
the gestational diabetic group. All patients with pre-existing
diabetes were either induced or had elective Caesarean before
reaching full term. Patients with gestational diabetes were
offered delivery at term. Failure to progress was diagnosed
based on Friedman’s curve.
Patient’s age, weight, gestational age at delivery, parity
and 3rd and 4th degree tears were recorded. Shoulder
dystocia was diagnosed when gentle traction failed to deliver
the shoulder and additional obstetric manoeuvres were
required. Birth trauma, including Erb’s palsy and clavicular/
humeral fractures in our birth registry, were recorded.
The main outcome was the effect of DM on the decision
to allow macrosomic baby vaginal delivery. Other outcomes
included the rate of emergency LSCS with trial of labour,
effect of previous delivery/maternal age/foetal weight on the
trial of labour and neonatal morbidity associated with
vaginal birth. Data were analysed using the StatsDirect sta-
tistical package. Two-sided ManneWhitney U tests were
used to compare the medians between two groups, and two-
sided unpaired t tests were used to compare the means be-
tween two groups. Chi square tests were used in crosstabs,
and FishereFreemaneHalton exact test was employed in
crosstabs when any cells had an expectation of less than 5. P-
values of less than 0.05 were considered statistically
significant.
Results
The incidence of macrocosmic babies represented
approximately 2.2% of all recorded deliveries (811 out of
36,827 cases). Approximately 78% (634/811) of patients did
not have gestational or pre-existing diabetes. Gestational
diabetes was noted in 18% (145/811) of patients, and pre-
existing diabetes was only found in 4% (32/811).
Thirty-four patients with glucose intolerance were added
to the gestational diabetes group. Approximately 25% of the
patients with gestational diabetes (26/111) were managed
with insulin during pregnancy, whereas the remaining ma-
jority (76.6%) were managed with diet. Three-fourths of
patients with pre-existing diabetes (24/32) were type 1, and
Table 2: Emergency Caesarean rate in patients allowed a trial
of vaginal birth.
No DM
555
GDM
114
Pre-existing DM
16
Emergency CS 122 88 (16%) 29 (25%) 5 (31%)
SVD 563 467 (84%) 85 (75%) 11 (69%)
Chi-square P ¼ 0.0187.
Table 3: Characteristics of patients who were allowed a trial of
labour.
Emergency CS SVD P-value
Patient mean age
in years
30.4 (29.3e31.5) 31.2 (30.8e31.8) P ¼ 0.1605
Gestational mean
age in weeks
39 (35e41) 41 (35e41) P < 0.0001
Foetal mean
weight in kg
4.18 (4e5.34) 4.15 (4e5.37) P ¼ 0.06
Different types of diabetes mellitus and modes of delivery 57the remaining (8/32) were type 2 diabetics. None of the
diabetic patients received oral anti-diabetic therapy during
pregnancy within the study period.
Trial of normal labour (TOL) was offered to 685 (84.4%)
of the total number of patients in this study. Diabetes
significantly influenced the mode of delivery (MOD), with a
trend of offering more elective LSCS to patients with pre-
existing diabetes (Table 1). Only 50% of patients with pre-
existing diabetes and large babies were given the trial of
vaginal birth. This number increased to 78.6% in the GDM
group (P< 0.0001) with a linear trend (P< 0.0001) (Table 1).
Unfortunately, 12.5% of non-diabetic patients with large
babies were delivered by elective LSCS.
Out of the 685 patients, 563 (82.1%) had a normal
vaginal delivery when allowed a normal trial of labour. The
emergency LSCS rates in patients allowing vaginal birth
were significantly different between the study groups
(P ¼ 0.018).
In total, 69% of patients with pre-existing diabetes and
large babies underwent successful vaginal birth. The emer-
gency LSCS rate in patients with large babies and non-
diabetic was 16% compared with 25% in the gestational
diabetic group (P ¼ 0.01) (Table 2). The emergency LSCS
group included patients who had LSCS due to other
obstetric reasons and not necessarily ‘failure to progress’ in
labour.
The present analysis confirmed that patient’s age and
foetal weight had no effect on successful trial of vaginal birth
with macrosomic babies. The mean age of patients who had
emergency LSCS was 30.4 years compared with 31.2 for the
vaginal delivery group. The median foetal weight was similar
for the 2 groups (4.18 Kgs and 4.15 Kgs) (Table 3). There was
a trend toward emergency Caesarean for patients with a
median gestational age of 39 weeks compared with those at
41 weeks (P < 0.0001).
The majority of screened patients (90%) had a previous
delivery, including a previous LSCS. No difference was
noted in the elective Caesarean rate between primigravida
and patients with previous delivery (18% compared with
15%, respectively). Primigravida in the present analysis
exhibited an increased rate of emergency LSCS compared
with patients with previous delivery (56% vs. 14%)
(Table 4).
The emergency Caesarean rate for ‘failure to progress’
was significantly increased in patients with pre-existing dia-
betes (31%) compared with patients with no diabetes (9%).
For patients with gestational diabetes, the ‘failure to prog-
ress’ rate was 16.7% (Table 5).
None of the patients who delivered vaginally had an
extended vaginal tear of the 3rd or 4th degree. Furthermore,
there were no reported serious complications, such as aTable 1: The effect of DM on the decision to allow macrosomic
babies a trial of vaginal birth.
No DM
634
GDM
145
Pre-existing DM
32
Allowed TOL 685 555 (87.5%) 114 (78.6%) 16 (50%)
Elective CS 126 79 (12.5%) 31 (21.4%) 16 (50%)
Chi-square P < 0.0001.ruptured uterus or hysterectomy for postpartum haemor-
rhage. None of the 22 cases of shoulder dystocia reported in
the study had pre-existing diabetes. Shoulder dystocia was
reported in 6 patients (27%) with gestational diabetes, 3 of
whom were receiving insulin treatment. The median foetal
weight of these patients was 4.2 kgs. Shoulder dystocia also
occurred in 8 patients with no diabetic history who delivered
after 41 weeks. It is important to note that all diabetic
mothers delivered before 40 weeks, yet shoulder dystocia was
not prevented. A single case of clavicular fracture was re-
ported in a 4-kg baby whose mother had diet-controlled
gestational diabetes. Another case of Erb’s palsy was re-
ported for a 4.5-kg baby whose mother was non-diabetic.
Fortunately, the injury resolved without any permanent
damage.Discussion
In current obstetric practice, a macrosomic foetus repre-
sents a clinical challenge, especially during the process of
vaginal delivery. The rate of macrosomia was estimated at
(10.19%) in a recent Algerian study; their foetal complica-
tions primarily involved neonatal infections (88%), followed
by shoulder dystocia.11
A number of studies assessed the most appropriate and
safe approach to deliver macrosomic babies. Inducing labour
prior to 40 weeks of gestation was offered to some women
with predicted foetal macrosomia. This approach would helpTable 4: Mode of delivery and previous birth.
Primigravida
78
Previous delivery
733
Elective CS 126 14 (18%) 112 (15%)
Emergency LSCS 122 36 (56%) 86 (14%)
SVD 563 28 (44%) 535 (86%)
Chi-square P < 0.0001.
Table 5: Emergency Caesarean rate for ‘failure to progress’ in
patients allowed a trial of vaginal birth.
No DM
513
GDM
102
Pre-existing DM
16
Emergency CS 68 46 (9%) 17 (16.7%) 5 (31%)
SVD 563 467 (91%) 85 (83.3%) 11 (69%)
FishereFreemaneHalton exact P ¼ 0.003, Linear trend
P ¼ 0.0006.
B.S. Al Omran et al.58mothers to achieve a normal vaginal delivery before the in-
crease in foetal weight, which causes foetal and maternal
injuries.12
Cheng et al. reported a reduction in the risk of CSD if the
foetal weight was known at 39 weeks and labour had been
induced.13 However, Combs’ group suggested that induction
of labour increases the Caesarean section rate without
altering perinatal complications.14
Elective CS seems to be safe with regard to preventing
most of the complications associated with such a delivery.
However, the number of Caesareans required to prevent a
single case of permanent injury is so high that it does not
justify its use for all cases of macrosomia. In addition, the
procedure places the mother and subsequent pregnancies at
risk, as noted in a study conducted in the Al-Jouf region,
KSA.15,16 Alsammani and co-workers also reported that the
high CS rate observed in their study at the Maternity and
Child Hospital, Qassim, KSA was mainly due to elective CS
in accordance with hospital policy and not to other risk
factors, such as foeto-pelvic disproportion.17
In our study, approximately 88% of patients with mac-
rosomic babies were allowed a vaginal trial, and 84% of these
achieved their goal. However, we noted a longer gestational
age (41 weeks) in the group that achieved vaginal delivery
compared with patients who had an emergency Caesarean
section (39 weeks). This finding could be due to poor patience
compliance or failure to follow-up in the obstetric outpatient
clinic. Following the exclusion of other causes of emergency
abdominal delivery, the actual rate of ‘failure to progress’ in
those patients was only 9%. Our analysis shows no signifi-
cant difference in patient age and foetal weight with regard to
a successful trial of vaginal birth with a macrosomic baby.
Adding diabetes to the history would dramatically affect
the decision regarding the mode of delivery in macrosomic
babies. Suspected macrosomic foetuses prompt many clini-
cians to perform elective CSs in women with diabetes.18
However, no consensus is available regarding the estimated
foetal weight at which elective abdominal delivery is
deemed to be necessary in diabetic patients. Menticoglou
et al. did not justify a policy of routine CS for all
macrosomic babies to prevent mechanical difficulties at
delivery.18
Instead, these researchers suggest that a prudent super-
vised trial of vaginal delivery is the preferred approach.19
They stated that most large babies are delivered without
shoulder dystocia. If such a complication is encountered, it
could be managed by an experienced obstetrician.
We found that 79% of gestational diabetic patients with a
large baby were offered a trial of vaginal birth, which was
achieved in 75% of patients. However, 50% of patients witha large baby and pre-existing diabetes were offered elective
abdominal delivery immediately. After excluding other in-
dications for elective Caesarean in that group, 30% of pa-
tients only had an elective abdominal birth due to
macrosomia.
In total, 3.9% of vaginally delivered patients had shoulder
dystocia, with neonatal injuries reported in 0.35%. The rate
of shoulder dystocia in our cases is less than that reported by
Rouse (13.5e52.5%).20 This finding could be due to under
reporting or misdiagnosis in our population. However, our
rate is similar to the 4.1% reported by Mulik’s group.21
The association of a history of previous CS with the
current foetal macrosomic state has become a common
clinical problem. Previous observations support a policy of
trial of labour in this group of women with an estimated
foetal weight greater than 4000 g.22
Later studies indicate that a previous vaginal birth pre-
dicts success in women with macrosomic foetuses undergoing
trial of labour after a previous CSD.22,23 Furthermore, the
indication for a previous CSD may affect the success rate
of induction. Failure to progress, as an indication for
previous CS, seems to be associated with a lower success
rate during trial of labour.23 Obesity appears to be an
independent risk factor for failed trial of labour in women
with previous CSD.24
In our study, there was no difference in the elective
Caesarean rate between primigravida and patients with
previous delivery (18% vs. 15%, respectively) (Table 4). Of
note, 41.2% of patients with previous delivery in the
elective list had a previous Caesarean section. However,
primigravida patients had a higher rate of emergency LSCS
compared with patients with previous delivery (56% vs.
14%) (Table 5). Unfortunately, because the study was
retrospective, it was not possible to analyse the mode of
delivery in patients who had macrosomic babies with
previous CSD and the effect of diabetes on the success of
vaginal birth. Additionally, the impact of maternal body
mass index (BMI) on clinical and sonographic antenatal
assessment is of paramount importance, and it was not
possible to address this issue in this analysis.Conclusions
The assessment of the management approach for more
than 800 patients over a 10-year period at the BDFMH
confirmed that the rationale for allowing a trial of labour
exists based on a patient’s preference and data published in
the literature. The obstetric history of any given patient with
a large baby should be taken into consideration before
making any decision. A history of a previous difficult de-
livery with a mal presentation is one of the factors against
operative vaginal delivery. Many patients are multi-parous
and want to avoid CSD, especially those who have experi-
enced a previous uncomplicated delivery for a macrosomic
infant. Our analysis demonstrated that diabetic patients with
a large baby should be assessed on an individual basis and
allowed a trial of vaginal birth. Unfortunately, the conclu-
sions drawn from our analysis are limited by the retrospec-
tive approach of the study. Further well designed prospective
analyses would shed more light on foetuses mislabelled as
large for their gestation date due to high BMI and the actual
Different types of diabetes mellitus and modes of delivery 59harm of denying vaginal delivery based on ultrasound find-
ings. In addition, patient perception of a difficult delivery
with a large baby and its effect on her choice of accepting a
vaginal trial must be taken into consideration.
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